# Modafinil to Prevent Postoperative Cognitive Decline

> **NCT03914118** · PHASE2 · COMPLETED · sponsor: **The Cooper Health System** · enrollment: 137 (actual)

## Conditions studied

- Postoperative Cognitive Dysfunction

## Interventions

- **DRUG:** Preoperative modafinil + postoperative placebo
- **DRUG:** Preoperative modafinil + postoperative modafinil
- **DRUG:** Preoperative placebo + postoperative placebo

## Key facts

- **NCT ID:** NCT03914118
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-01
- **Primary completion:** 2013-01-31
- **Final completion:** 2013-01-31
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2023-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914118, "Modafinil to Prevent Postoperative Cognitive Decline". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03914118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*